Skip to content
MedsAcross

Medicine

Anticoagulant Sodium Citrate 40 mg/mL solution

Trisodium · Extracorporeal · Laboratorios Grifols
Available on requestPrescription onlyUS FDA

Anticoagulant Sodium Citrate 40 mg/mL solution is a prescription medicine containing Trisodium for extracorporeal use, marketed by Laboratorios Grifols, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Store at 20°C to 25°C (68°F to 77°F), excursions…

Key facts

Active ingredient (INN)
Trisodium
Brand
Anticoagulant Sodium Citrate
Strength
40 mg/mL
Dosage form
Solution
Route
Extracorporeal
Packs
30 bags, 39 bags
Marketing authorisation holder
Laboratorios Grifols
Manufacturer
Laboratorios Grifols
Origin register
US FDA, United States
Storage
Protect from freezing. Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Brief exposure up to 40°C (104°F) does not adversely affect the product.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 October 2019
Identifiers
DailyMed set ID db8334be-5b8b-4811-811a-efbe32b6d147NDC 76297-006Application BA125697

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
30 bag in 1 carton / 250 mL in 1 bag76297-006-03Laboratorios Grifols25 October 2019
39 bag in 1 carton / 250 mL in 1 bag76297-006-04Laboratorios Grifols25 October 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Trisodium 40 mg/mL solution.

Compare 1

Other strengths and forms of Trisodium

Clinical summary

Trisodium is an anti-coagulant. It is available as injection and solution for intravenous and extracorporeal use. MedsAcross supplies Trisodium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Trisodium

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Anticoagulant Sodium Citrate 40 mg/mL solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.